Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Hormonal Regulation01:33

Hormonal Regulation

30.3K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.3K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Modeling in Therapy01:26

Modeling in Therapy

821
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
821
Human Genetics01:28

Human Genetics

2.0K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026
Same author

The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.

The British journal of psychiatry : the journal of mental science·2026
Same author

Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.

JAMA network open·2026
Same author

Thank You to the JCP Community.

The Journal of clinical psychiatry·2026
Same author

The pregnant body project pilot RCT protocol: Preventing disordered eating behaviors in high-risk pregnant individuals.

Contemporary clinical trials·2025
Same journal

2026 Annual Meeting: President-Elect Address.

The American journal of psychiatry·2026
Same journal

2026 Annual Meeting: CEO and Medical Director's Address.

The American journal of psychiatry·2026
Same journal

Reports to the Membership.

The American journal of psychiatry·2026
Same journal

Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

The American journal of psychiatry·2026
Same journal

2026 Annual Meeting: Presidential Address.

The American journal of psychiatry·2026
Same journal

Represcribing Previously Used Antipsychotics: Response to So.

The American journal of psychiatry·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

9.7K

ADHD and pregnancy.

Marlene P Freeman

    The American Journal of Psychiatry
    |July 2, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Stimulant medication for Attention Deficit Hyperactivity Disorder (ADHD) in pregnant women requires careful risk-benefit assessment. While major birth defects are not linked, more research is needed on long-term behavioral effects.

    More Related Videos

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
    05:48

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

    Published on: June 12, 2020

    5.4K
    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
    05:44

    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

    Published on: May 17, 2024

    1.2K

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
    13:09

    Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

    Published on: April 1, 2018

    9.7K
    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
    05:48

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

    Published on: June 12, 2020

    5.4K
    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
    05:44

    Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

    Published on: May 17, 2024

    1.2K

    Area of Science:

    • Perinatal Psychiatry
    • Neurodevelopmental Disorders
    • Pharmacology

    Background:

    • Increasing recognition and treatment of Attention Deficit Hyperactivity Disorder (ADHD) in women of reproductive age.
    • Lack of established guidelines for managing ADHD pharmacotherapy during pregnancy and postpartum.
    • Growing need to address the risk-benefit profile of ADHD medications in perinatal mental health.

    Observation:

    • Stimulant medications are commonly used for ADHD, raising concerns about in utero exposure.
    • Current data suggest stimulants are not associated with major congenital malformations.
    • Limited human data exist on potential behavioral teratogenicity and long-term effects of prenatal stimulant exposure.

    Findings:

    • Treatment decisions for ADHD during pregnancy depend on illness severity, comorbidities, and functional impairment.
    • Key considerations include maternal safety (e.g., driving) and occupational functioning.
    • In some cases, the benefits of stimulant treatment may outweigh the potential risks of exposure.

    Implications:

    • Highlights the need for further research into the neurodevelopmental and behavioral outcomes of children exposed to stimulants in utero.
    • Emphasizes the importance of individualized treatment plans in perinatal ADHD management.
    • Informs clinical practice regarding the complex decision-making process for stimulant use during pregnancy and the postpartum period.